Substantiating claims under the BPR
Human Hygiene (Product Type 1)
Learn to support your claims using relevant efficacy data
In this whitepaper, Dr Aiden Robertson outlines what general claims are permitted under the BPR with a focus on disinfectants intended for direct applications to humans (Product Type 1). In light of the COVID-19 outbreak, particular emphasis is given to virucidal claims. The substantiation of claims made for a biocidal product through relevant efficacy testing is also discussed.
Fill in this form to read the Whitepaper
About the Author
Dr Aiden Robertson
Senior Chemistry Consultant
Aiden is an experienced PhD chemist with over 3 years’ experience in chemicals regulation. His specialist area is supramolecular chemistry and solid-state analytical chemistry but his technical experience in both REACH and Biocides means that he has worked with a broad range of organic, inorganic and biological substances, polymers, minerals, petroleum products and formulations.
